Design and characterisation of a novel environmentally responsive ophthalmic drug delivery system

European Journal of Parenteral and Pharmaceutical Sciences

Volumn 16, Issue 1, 2011, Pages 15-19

  Gattani, Surendra G ^a   Deshmukh, Prashant K ^a  

^a R C PATEL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH   (India)

Author keywords

Hpmc; Ion activated; Sodium alginate; Sustained release

Indexed keywords

ALGINIC ACID; BENZALKONIUM CHLORIDE; HYDROXYPROPYLMETHYLCELLULOSE; OFLOXACIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; CORNEA; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG DOSAGE FORM; DRUG FORMULATION; GELATION; MEAN RESIDENCE TIME; NONHUMAN; STAPHYLOCOCCUS AUREUS; SUSTAINED DRUG RELEASE;

EID: 79960744970     PISSN: 09644679     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Manvi FV, Manjappa AS. In situ forming hydrogels for sustained ophthalmic drug delivery. J Control Rel 2007; 122:119-134.
2. Bourlais CL, Acar L, Zia H, Sado PA. Ophthalmic drug delivery systems - recent advances. Progress Retinal Eye Res 1998; 17:33-58.
3. Saettone M, Salminen L. Ocular inserts for topical delivery. Adv Drug Deliv Rev 1995; 16:95-106.
4. ® in situ gels for ophthalmic use. Eur J Pharmaceut Sci 1998; 6:113-119.
5. Grzekowiak E. Biopharmaceutical availability of sulphadicramide from ocular ointments in vitro. Eur J Pharmaceut Sci 1998; 6:247-253.
6. Wei G, Xu H, Ding P, et al. Thermosetting gels with modulated gelation temperature for ophthalmic use: the rheological and gamma scintigraphic studies. J Control Rel 2002; 83:65-74.
7. Cohen S, Lobel E, Trevgoda A, Peled Y. A novel in-situ-forming ophthalmic drug delivery system from alginates undergoing gelation in the eye. J Control Rel 1997; 44:201-208.
8. Gurny R. Preliminary study of prolonged acting drug delivery system for the treatment of glaucoma. Pharmaceutica Acta Helvetiae 1981; 56(4-5):130-132.
9. Gurny R, Boye T, Ibrahim H. Ocular therapy with nanoparticulate systems for controlled drug delivery. J Control Rel 1985; 2:353-361.
10. Miller SC, Donovan MD. Effect of poloxamer 407 gel on the miotic activity of pilocarpine nitrate in rabbits. Int J Pharmaceut 1982; 12(2-3):147-152.
11. Desai SD, Blanchard J. In vitro evaluation of Pluronic F127-based controlled-release ocular delivery systems for pilocarpine. J Pharmaceut Sci 1998; 87:226-230.
12. Vadnere M, Amidon G, Lindenbaum S, Haslam JL. Thermodynamic studies on the gel-sol transition of some pluronic polyols. Int J Pharmaceut 1984; 22(2-3):207-218.
13. Spancake CW, Mitra AK, Kildsig DO. Kinetics of aspirin hydrolysis in aqueous solutions and gels of poloxamines (Tetronic 1508) influence of micro-environment. Int J Pharmaceut 1991; 75(2-3):231-239.
14. Rozier A, Manuel C, Groove J, Plazonnet B. Gelrite: a novel, ionactivated, in situ gelling polymer for ophthalmic vehicles. Effect on bioavailability of timolol. Int J Pharmaceut 1989; 57:163-168.
15. Sanzgiri YD, Maschi S, Crescenzi V, et al. Gellan-based systems for ophthalmic sustained delivery of methylprednisolone. J Control Rel 1993; 26:195-201.
16. Zhidong L, Jiawei L, Shufang N, et al. Study of an alginate/HPMCbased in situ gelling ophthalmic delivery system for Gatifloxacin. Int J Pharmaceut 2006; 315:12-17.
17. Srividya B, Cardoza RM, Amin PD. Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system. J Control Rel 2001; 73:205-211.